Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05LJF
|
||||
Former ID |
DNC013346
|
||||
Drug Name |
N-(1-(4-bromobenzyl)piperidin-4-yl)-2-naphthamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528638] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H23BrN2O
|
||||
Canonical SMILES |
C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)Br
|
||||
InChI |
1S/C23H23BrN2O/c24-21-9-5-17(6-10-21)16-26-13-11-22(12-14-26)25-23(27)20-8-7-18-3-1-2-4-19(18)15-20/h1-10,15,22H,11-14,16H2,(H,25,27)
|
||||
InChIKey |
WZCSZVSNRKEGGN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [528638] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.